Forecasting annual lung and bronchus cancer deaths using individual survival times

被引:1
|
作者
Jun, Duk Bin [1 ]
Kim, Kyunghoon [1 ]
Park, Myoung Hwan [2 ]
机构
[1] Korea Adv Inst Sci & Technol, Coll Business, Seoul, South Korea
[2] Hansung Univ, Dept Ind Engn, Seoul, South Korea
关键词
Health forecasting; Cancer; Survival analysis; Weibull mixture model; Unobserved heterogeneity; PREDICTING US; REGRESSION; MODELS; HETEROGENEITY; COUNTS;
D O I
10.1016/j.ijforecast.2015.05.002
中图分类号
F [经济];
学科分类号
02 ;
摘要
Accurate forecasts of the numbers of cancer deaths are critical not only for allocating government health and welfare budgets, but also for providing guidance to the related industries. We suggest a framework for predicting the annual numbers of cancer deaths by modeling individual survival times. A Weibull mixture model with individual covariates and unobserved heterogeneity is proposed for examining the effects of demographic variables on individual survival times and predicting the annual number of cancer deaths by adopting a bottom-up strategy. We apply the suggested framework to a survival analysis of lung and bronchus cancer patients in the United States and provide a comparison with the forecast results obtained from previous studies. A comparison of our results with those of various benchmarks shows that our proposed model performs better for predicting annual numbers of cancer deaths. Furthermore, by segmenting patients based on age, sex, and race, we are able to specify the differences between groups and assess the group-specific survival probabilities within a given period. Our results show that older, female, and white patients survive significantly longer than younger, male, and black patients. Also, patients diagnosed in recent years survive significantly longer than those diagnosed a long time ago. (C) 2015 International Institute of Forecasters. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:168 / 179
页数:12
相关论文
共 31 条
  • [21] The effect of warfarin therapy on breast, colorectal, lung, and prostate cancer survival: a population-based cohort study using the Clinical Practice Research Datalink
    M. A. O’Rorke
    L. J. Murray
    C. M. Hughes
    M. M. Cantwell
    C. R. Cardwell
    Cancer Causes & Control, 2015, 26 : 355 - 366
  • [22] Long-term survival prediction in lung cancer patients with type 2 diabetes using machine learning: a 20-year cohort study
    Huang, Junjie
    Zhong, Claire Chenwen
    Li, Zhaojun
    Jiang, Yu
    Yang, Zehuan
    Huang, Ziwei
    Dou, Qi
    Li, Yu
    Wong, Martin C. S.
    LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2025, 55 : 106 - 106
  • [23] Self-selection in a population-based cohort study: impact on health service use and survival for bowel and lung cancer assessed using data linkage
    Creighton, Nicola
    Purdie, Stuart
    Soeberg, Matthew
    Walton, Richard
    Baker, Deborah
    Young, Jane
    BMC MEDICAL RESEARCH METHODOLOGY, 2018, 18
  • [24] Self-selection in a population-based cohort study: impact on health service use and survival for bowel and lung cancer assessed using data linkage
    Nicola Creighton
    Stuart Purdie
    Matthew Soeberg
    Richard Walton
    Deborah Baker
    Jane Young
    BMC Medical Research Methodology, 18
  • [25] KI-basierte Analyse von KrebsregisterdatenPotenziale am Beispiel der Überlebenszeitanalyse von LungenkrebsAI-based analysis of cancer registry dataPotentials using the example of survival time analysis of lung cancer
    Sebastian Germer
    Christiane Rudolph
    Alexander Katalinic
    Natalie Rath
    Katharina Rausch
    Heinz Handels
    Forum, 2024, 39 (4) : 258 - 263
  • [26] External validation of a tumor growth inhibition-overall survival model in non-small-cell lung cancer based on atezolizumab studies using alectinib data
    Kassir, Nastya
    Chan, Phyllis
    Dang, Steve
    Bruno, Rene
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2023, 92 (03) : 205 - 210
  • [27] External validation of a tumor growth inhibition-overall survival model in non-small-cell lung cancer based on atezolizumab studies using alectinib data
    Nastya Kassir
    Phyllis Chan
    Steve Dang
    René Bruno
    Cancer Chemotherapy and Pharmacology, 2023, 92 : 205 - 210
  • [28] Early response evaluation using primary tumor and nodal imaging features to predict progression-free survival of locally advanced non-small cell lung cancer
    Zhang, Nasha
    Liang, Rachel
    Gensheimer, Michael F.
    Guo, Meiying
    Zhu, Hui
    Yu, Jinming
    Diehn, Maximilian
    Loo, Bill W., Jr.
    Li, Ruijiang
    Wu, Jia
    THERANOSTICS, 2020, 10 (25): : 11707 - 11718
  • [29] Forecasting PM2.5-induced lung cancer mortality and morbidity at county level in China using satellite-derived PM2.5 data from 1998 to 2016: a modeling study
    Liao, Wei-Bin
    Ju, Ke
    Zhou, Qian
    Gao, Ya-Min
    Pan, Jay
    ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH, 2020, 27 (18) : 22946 - 22955
  • [30] The Positive Lymph Node Ratio Predicts Survival in T1-4N1-3M0Non-Small Cell Lung Cancer: A Nomogram Using the SEER Database
    Liao, Yi
    Yin, Guofang
    Fan, Xianming
    FRONTIERS IN ONCOLOGY, 2020, 10